Clinical Trial Update: Hormonal Receptor (HR)-Positive HER2 Negative Breast Cancer Patients Treated With Preoperative ELacestrant and PULSAR Radiotherapy [Phase 2]

View source ↗

Summary

This entry notes a Phase 2 clinical trial evaluating preoperative elacestrant in combination with PULSAR radiotherapy for hormone receptor-positive, HER2-negati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Hormone Receptor-positive Breast Cancer

Drugs mentioned

• Elacestrant (elacestrant)

Snippet

Sponsor: Azienda Ospedaliero-Universitaria Careggi | Conditions: Breast Cancer Patients, Breast Cancer Early Stage Breast Cancer (Stage 1-3) | Phase 2 | Status: NOT_YET_RECRUITING